Skip to main content

Tenax Therapeutics, Inc.

TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000034956

In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.

Members of Congress who traded TENX

No member of Congress has reported a trade in Tenax Therapeutics, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.